Tomasz E Romer is an endocrinologist in private practice in Warsaw. Prior to this he was Head of the Department of Endocrinology at the Child Health Memorial Research Institute in Warsaw, where he also founded a Paediatric Endocrinology Unit. Professor Romer has been a member of the European Society of Paediatric Endocrinology since 1985 and was President and organiser of the 38th Annual Meeting in Warsaw in 1999. He has also been principal investigator in the pre-registration clinical trials of Maxomate (Sanofi), Accretropin (Cangene), Valtropine (Biopartners) and Omnitrope (Sandoz). Professor Romer obtained his PhD in 1964 and his professorship in 1985.

Related Articles

• The Role of Recombinant Human Growth Hormone Biosimilars in the Management of Growth Disorders